GSK3B and neoplasm: 1, High levels of IGF1 and insulin in obesity downregulate GSK3B activity by phosphorylating its serine residue, upregulation CXCL1, CCL20, and IL-6 expression (84)1、 2, Tumor antigens deficiency (95)